Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Encompass Health
(NYSE:EHC)
Intraday
$82.46
2.13
[2.65%]
After-Hours
$82.46
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$82.46
2.13
[2.65%]
At close: Apr 23
$82.46
0
[0.00%]
After Hours: 4:20PM EDT
Get Report
Watch
Q1 2024 earnings announcement after the market close today
Conference call scheduled tomorrow at 10:00 AM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Encompass Health Stock (NYSE:EHC)
Encompass Health Stock (NYSE: EHC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 16, 2024
Here's How Much You Would Have Made Owning Encompass Health Stock In The Last 15 Years
Benzinga Insights
-
Apr 16, 2024, 4:00PM
Wednesday, April 03, 2024
Encompass Health Announces Preliminary Plans To Build A 50-Bed Inpatient Rehabilitation Hospital In San Antonio
Benzinga Newsdesk
-
Apr 3, 2024, 4:45PM
Friday, March 29, 2024
Marijuana Stock Movers For March 29, 2024
Benzinga Insights
-
Mar 29, 2024, 4:30PM
Thursday, March 28, 2024
Cannabis Stock Gainers And Losers From March 28, 2024
Benzinga Insights
-
Mar 28, 2024, 4:30PM
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Mar 28, 2024, 1:35PM
Encompass Health shares are trading higher after Barclays maintained an Overweight rating on the stock and raised its price target from $95 to $101.
Benzinga Newsdesk
-
Mar 28, 2024, 11:07AM
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
-
Mar 28, 2024, 11:00AM
Encompass Health Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Benzinga Insights
-
Mar 28, 2024, 9:00AM
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $101
Benzinga Newsdesk
-
Mar 28, 2024, 8:07AM
Wednesday, March 13, 2024
Looking Into Encompass Health's Recent Short Interest
Benzinga Insights
-
Mar 13, 2024, 12:45PM
Thursday, March 07, 2024
Encompass Health And Piedmont Disclosed They Have Been Awarded A Certificate Of Need To Build A Freestanding, 40-bed Inpatient Rehabilitation Hospital In Loganville, Georgia
Benzinga Newsdesk
-
Mar 7, 2024, 7:55AM
Wednesday, March 06, 2024
Cracking The Code: Understanding Analyst Reviews For Encompass Health
Benzinga Insights
-
Mar 6, 2024, 7:00AM
Barclays Initiates Coverage On Encompass Health with Overweight Rating, Announces Price Target of $95
Benzinga Newsdesk
-
Mar 6, 2024, 6:36AM
Monday, February 26, 2024
Looking Into Encompass Health's Recent Short Interest
Benzinga Insights
-
Feb 26, 2024, 11:15AM
Thursday, February 15, 2024
Encompass Health Announces Preliminary Plans To Build A 60-Bed Inpatient Rehabilitation Hospital In Avondale, Arizona
Benzinga Newsdesk
-
Feb 15, 2024, 4:56PM
Friday, February 09, 2024
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $86
Benzinga Newsdesk
-
Feb 9, 2024, 4:47PM
RBC Capital Reiterates Outperform on Encompass Health, Maintains $83 Price Target
Benzinga Newsdesk
-
Feb 9, 2024, 10:57AM
Mizuho Maintains Buy on Encompass Health, Raises Price Target to $82-Report released on 8th February 2024
Benzinga Newsdesk
-
Feb 9, 2024, 10:49AM
Wednesday, February 07, 2024
Encompass Health Sees 2024 Adj. EPS $3.77-$4.06 vs $3.84 Est., Revenue $5.2B-$5.3B vs $5.19B Est.
Benzinga Newsdesk
-
Feb 7, 2024, 5:19PM
Encompass Health: Q4 Earnings Insights
Benzinga Insights
-
Feb 7, 2024, 4:45PM
Encompass Health Q4 2023 Adj EPS $0.95 Beats $0.82 Estimate, Sales $1.25B Beat $1.24B Estimate
Benzinga Newsdesk
-
Feb 7, 2024, 4:40PM
Earnings Scheduled For February 7, 2024
Benzinga Insights
-
Feb 7, 2024, 5:13AM
Tuesday, February 06, 2024
Preview: Encompass Health's Earnings
Benzinga Insights
-
Feb 6, 2024, 10:03AM
Tuesday, January 16, 2024
Cannabis Stock Gainers And Losers From January 16, 2024
Benzinga Insights
-
Jan 16, 2024, 4:30PM
Stephens & Co. Reiterates Overweight on Encompass Health, Maintains $85 Price Target
Benzinga Newsdesk
-
Jan 16, 2024, 9:25AM
Thursday, October 26, 2023
Encompass Health Q3 2023 Adj. EPS $0.86 Beats $0.77 Estimate, Sales $1.21B Beat $1.19B Estimate
Benzinga Newsdesk
-
Oct 26, 2023, 4:34PM
Earnings Scheduled For October 26, 2023
Benzinga Insights
-
Oct 26, 2023, 7:20AM
Thursday, September 28, 2023
The Latest Analyst Ratings for Encompass Health
Benzinga Insights
-
Sep 28, 2023, 12:00PM
RBC Capital Reiterates Outperform on Encompass Health, Maintains $83 Price Target
Benzinga Newsdesk
-
Sep 28, 2023, 10:34AM
Tuesday, September 26, 2023
Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 26, 2023
Benzinga Insights
-
Sep 26, 2023, 5:30PM
Tuesday, August 22, 2023
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor
Piero Cingari
-
Aug 22, 2023, 12:02PM
Friday, August 18, 2023
Encompass Health President & CEO Acquires 25,330 Shares After Exercising Company Stock Options
Benzinga Insights
-
Aug 18, 2023, 11:00AM
Tuesday, August 08, 2023
Analyst Expectations for Encompass Health's Future
Benzinga Insights
-
Aug 8, 2023, 3:00PM
RBC Capital Maintains Outperform on Encompass Health, Raises Price Target to $83
Benzinga Newsdesk
-
Aug 8, 2023, 11:31AM
Friday, August 04, 2023
Barclays Maintains Equal-Weight on Encompass Health, Raises Price Target to $70
Benzinga Newsdesk
-
Aug 4, 2023, 11:35AM
Credit Suisse Maintains Outperform on Encompass Health, Raises Price Target to $80
Benzinga Newsdesk
-
Aug 4, 2023, 9:28AM
Thursday, August 03, 2023
Raymond James Maintains Strong Buy on Encompass Health, Raises Price Target to $85
Benzinga Newsdesk
-
Aug 3, 2023, 12:40PM
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $82
Benzinga Newsdesk
-
Aug 3, 2023, 11:48AM
Mizuho Maintains Buy on Encompass Health, Raises Price Target to $77
Benzinga Newsdesk
-
Aug 3, 2023, 8:32AM
Barclays Maintains Equal-Weight on Encompass Health, Raises Price Target to $71
Benzinga Newsdesk
-
Aug 3, 2023, 7:27AM
Wednesday, August 02, 2023
Encompass Health Corporation shares are trading higher after the company reported better-than-expected Q2 financial results and issued FY23 revenue guidance above estimates.
Benzinga Newsdesk
-
Aug 2, 2023, 1:00PM
Tuesday, August 01, 2023
Encompass Health Sees FY23 Revenue $4.75B-$4.781B Vs $4.74B Est
Benzinga Newsdesk
-
Aug 1, 2023, 4:40PM
Encompass Health Raises Guidance
Benzinga Newsdesk
-
Aug 1, 2023, 4:38PM
Encompass Health Q2 EPS $0.95 Beats $0.74 Estimate, Sales $1.19B Beat $1.16B Estimate
Benzinga Newsdesk
-
Aug 1, 2023, 4:38PM
Earnings Scheduled For August 1, 2023
Benzinga Insights
-
Aug 1, 2023, 4:06AM
Monday, July 31, 2023
Encompass Health's Earnings: A Preview
Benzinga Insights
-
Jul 31, 2023, 12:01PM
Thursday, July 20, 2023
Stephens & Co. Reiterates Overweight on Encompass Health, Maintains $78 Price Target
Benzinga Newsdesk
-
Jul 20, 2023, 9:09AM
Thursday, June 29, 2023
What 9 Analyst Ratings Have To Say About Encompass Health
Benzinga Insights
-
Jun 29, 2023, 3:00PM
Stephens & Co. Maintains Overweight on Encompass Health, Raises Price Target to $78
Benzinga Newsdesk
-
Jun 29, 2023, 10:31AM
Tuesday, May 02, 2023
RBC Capital Maintains Outperform on Encompass Health, Raises Price Target to $70
Benzinga Newsdesk
-
May 2, 2023, 9:13AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch